Core Laboratories N.V. Company Profile (NYSE:CLB)

About Core Laboratories N.V. (NYSE:CLB)

Core Laboratories N.V. logoCore Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.

Industry, Sector and Symbol:
  • Sector: Oils/Energy
  • Industry: Oil Related Services and Equipment
  • Sub-Industry: N/A
  • Symbol: NYSE:CLB
  • CUSIP: N/A
  • Web: www.corelab.com
Capitalization:
  • Market Cap: $4.3 billion
  • Outstanding Shares: 44,138,000
Average Prices:
  • 50 Day Moving Avg: $92.99
  • 200 Day Moving Avg: $103.90
  • 52 Week Range: $86.55 - $125.83
P/E:
  • Trailing P/E Ratio: 59.82
  • Foreward P/E Ratio: 35.72
  • P/E Growth: 1.21
Sales & Book Value:
  • Annual Revenue: $614.73 million
  • Price / Sales: 7.00
  • Book Value: $3.34 per share
  • Price / Book: 29.19
Dividend:
  • Annual Dividend: $2.20
  • Dividend Yield: 2.2%
Profitability:
  • EBIDTA: $123.03 million
  • Net Margins: 11.80%
  • Return on Equity: 49.29%
  • Return on Assets: 13.35%
Debt:
  • Debt-to-Equity Ratio: 1.54%
  • Current Ratio: 2.05%
  • Quick Ratio: 1.69%
Misc:
  • Average Volume: 753,770 shs.
  • Beta: 1.6
  • Short Ratio: 14.53
 

Frequently Asked Questions for Core Laboratories N.V. (NYSE:CLB)

What is Core Laboratories N.V.'s stock symbol?

Core Laboratories N.V. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

How often does Core Laboratories N.V. pay dividends? What is the dividend yield for Core Laboratories N.V.?

Core Laboratories N.V. declared a quarterly dividend on Thursday, July 6th. Shareholders of record on Monday, July 17th will be given a dividend of $0.55 per share on Monday, August 14th. This represents a $2.20 dividend on an annualized basis and a yield of 2.26%. The ex-dividend date of this dividend is Thursday, July 13th. View Core Laboratories N.V.'s Dividend History.

How were Core Laboratories N.V.'s earnings last quarter?

Core Laboratories N.V. (NYSE:CLB) released its quarterly earnings data on Monday, July, 24th. The company reported $0.52 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.51 by $0.01. The business earned $163.90 million during the quarter, compared to analyst estimates of $168.23 million. Core Laboratories N.V. had a return on equity of 49.29% and a net margin of 11.80%. Core Laboratories N.V.'s quarterly revenue was up 10.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.35 EPS. View Core Laboratories N.V.'s Earnings History.

When will Core Laboratories N.V. make its next earnings announcement?

Core Laboratories N.V. is scheduled to release their next quarterly earnings announcement on Monday, October, 23rd 2017. View Earnings Estimates for Core Laboratories N.V..

What guidance has Core Laboratories N.V. issued on next quarter's earnings?

Core Laboratories N.V. updated its third quarter earnings guidance on Tuesday, September, 5th. The company provided EPS guidance of ~$0.44 for the period, compared to the Thomson Reuters consensus estimate of $0.56. The company issued revenue guidance of ~$161 million, compared to the consensus revenue estimate of $168.53 million.

Where is Core Laboratories N.V.'s stock going? Where will Core Laboratories N.V.'s stock price be in 2017?

13 equities research analysts have issued 12-month target prices for Core Laboratories N.V.'s stock. Their forecasts range from $91.00 to $136.00. On average, they anticipate Core Laboratories N.V.'s stock price to reach $113.70 in the next year. View Analyst Ratings for Core Laboratories N.V..

Who are some of Core Laboratories N.V.'s key competitors?

Who are Core Laboratories N.V.'s key executives?

Core Laboratories N.V.'s management team includes the folowing people:

  • David M. Demshur, Chairman of the Supervisory Board, President, Chief Executive Officer
  • Richard L. Bergmark, Chief Financial Officer, Executive Vice President, Member of the Supervisory Board
  • Monty L. Davis, Chief Operating Officer, Senior Vice President
  • Christopher S. Hill, Vice President, Chief Accounting Officer
  • Mark F. Elvig, Vice President, Secretary, General Counsel
  • Gwendolyn Y. Schreffler, Vice President, Corporate Development & Investor Relations
  • Martha Z. Carnes, Member of the Supervisory Board
  • Charles L. Dunlap, Member of the Supervisory Board
  • Jan Willem Sodderland, Member of the Supervisory Board
  • Michael Straughen, Member of the Supervisory Board

Who owns Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock is owned by a number of of institutional and retail investors. Top institutional shareholders include WCM INVESTMENT MANAGEMENT (10.17%), WCM Investment Management CA (10.04%), Vanguard Group Inc. (8.32%), Sustainable Growth Advisers LP (5.31%), Earnest Partners LLC (4.16%) and Kayne Anderson Rudnick Investment Management LLC (3.86%). Company insiders that own Core Laboratories N.V. stock include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Institutional Ownership Trends for Core Laboratories N.V..

Who sold Core Laboratories N.V. stock? Who is selling Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock was sold by a variety of institutional investors in the last quarter, including Royal Bank of Canada, RiverPark Advisors LLC, American Century Companies Inc., Macquarie Group Ltd., Jackson Square Partners LLC, Bank of Montreal Can, Wells Fargo & Company MN and Capital World Investors. View Insider Buying and Selling for Core Laboratories N.V..

Who bought Core Laboratories N.V. stock? Who is buying Core Laboratories N.V. stock?

Core Laboratories N.V.'s stock was purchased by a variety of institutional investors in the last quarter, including Sustainable Growth Advisers LP, WCM Investment Management CA, Neuberger Berman Group LLC, Sei Investments Co., JPMorgan Chase & Co., Forsta AP Fonden, Vanguard Group Inc. and Northern Trust Corp. Company insiders that have bought Core Laboratories N.V. stock in the last two years include Jan Willem Sodderland, Martha Z Carnes and Michael Straughen. View Insider Buying and Selling for Core Laboratories N.V..

How do I buy Core Laboratories N.V. stock?

Shares of Core Laboratories N.V. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Core Laboratories N.V.'s stock price today?

One share of Core Laboratories N.V. stock can currently be purchased for approximately $97.51.


MarketBeat Community Rating for Core Laboratories N.V. (NYSE CLB)
Community Ranking:  1.9 out of 5 (star)
Outperform Votes:  225 (Vote Outperform)
Underperform Votes:  359 (Vote Underperform)
Total Votes:  584
MarketBeat's community ratings are surveys of what our community members think about Core Laboratories N.V. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Core Laboratories N.V. (NYSE:CLB) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 7 Hold Ratings, 5 Buy Ratings
Consensus Rating:Hold (Score: 2.31)
Consensus Price Target: $113.70 (16.60% upside)

Analysts' Ratings History for Core Laboratories N.V. (NYSE:CLB)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/7/2017Royal Bank Of CanadaLower Price TargetOutperform -> Outperform$115.00 -> $112.00LowView Rating Details
9/1/2017Cowen and CompanyReiterated RatingHold$100.00MediumView Rating Details
8/24/2017Credit Suisse GroupUpgradeNeutral -> Outperform$110.00MediumView Rating Details
8/7/2017Morgan StanleyLower Price TargetOverweight -> Overweight$130.00 -> $125.00MediumView Rating Details
7/26/2017Citigroup Inc.Lower Price TargetNeutral$102.00 -> $100.00LowView Rating Details
7/26/2017Piper Jaffray CompaniesSet Price TargetHold$97.00MediumView Rating Details
4/22/2017ScotiabankSet Price TargetHold$136.00LowView Rating Details
4/21/2017ABN AmroUpgradeHoldLowView Rating Details
4/21/2017Loop CapitalUpgradeHold -> Buy$125.00 -> $130.00LowView Rating Details
3/23/2017Tudor PickeringInitiated CoverageHoldLowView Rating Details
12/7/2016StephensDowngradeEqual Weight -> Sell$91.00N/AView Rating Details
12/6/2016GuggenheimDowngradeBuy -> NeutralN/AView Rating Details
10/5/2016DA DavidsonInitiated CoverageBuy$136.00N/AView Rating Details
7/12/2016J P Morgan Chase & CoDowngradeNeutral -> UnderweightN/AView Rating Details
6/13/2016KLR GroupReiterated RatingBuy$166.00 -> $180.00N/AView Rating Details
4/23/2016SimmonsReiterated RatingHold$105.00 -> $115.00N/AView Rating Details
3/28/2016Howard WeilBoost Price Target$112.00N/AView Rating Details
2/10/2016ING GroupLower Price TargetHold$125.00 -> $112.00N/AView Rating Details
2/2/2016William BlairReiterated RatingOutperformN/AView Rating Details
1/29/2016SunTrust Banks, Inc.Lower Price TargetBuy$123.00 -> $109.00N/AView Rating Details
1/29/2016Iberia CapitalLower Price TargetOutperform$140.00 -> $115.00N/AView Rating Details
1/26/2016HSBC Holdings plcDowngradeHold -> ReduceN/AView Rating Details
1/11/2016Oppenheimer Holdings, Inc.Initiated CoverageMarket PerformN/AView Rating Details
9/30/2015Sterne Agee CRTLower Price TargetNeutral$113.00 -> $108.00N/AView Rating Details
(Data available from 9/22/2015 forward)

Earnings

Earnings History for Core Laboratories N.V. (NYSE:CLB)
Earnings by Quarter for Core Laboratories N.V. (NYSE:CLB)
Earnings History by Quarter for Core Laboratories N.V. (NYSE CLB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/23/2017$0.61N/AView Earnings Details
7/24/20176/30/2017$0.51$0.52$168.23 million$163.90 millionViewN/AView Earnings Details
4/19/20173/31/2017$0.39$0.42$150.44 million$157.81 millionViewN/AView Earnings Details
1/25/201712/31/2016$0.41$0.41$145.78 million$149.54 millionViewN/AView Earnings Details
10/19/2016Q316$0.38$0.38$155.72 million$143.50 millionViewN/AView Earnings Details
7/20/2016Q216$0.35$0.35$146.37 million$148.10 millionViewN/AView Earnings Details
4/20/2016Q116$0.37$0.37$161.24 million$153.65 millionViewN/AView Earnings Details
1/27/2016Q415$0.65$0.65$179.48 million$182.70 millionViewListenView Earnings Details
10/21/2015Q315$0.83$0.83$203.29 million$197.27 millionViewListenView Earnings Details
7/22/2015Q215$0.77$0.82$195.13 million$204.00 millionViewListenView Earnings Details
4/22/2015Q115$0.85$0.86$211.82 million$213.64 millionViewN/AView Earnings Details
1/28/2015Q414$1.54$1.54$280.18 million$278.60 millionViewN/AView Earnings Details
10/22/2014Q314$1.52$1.53$284.30 million$276.14 millionViewListenView Earnings Details
7/23/2014Q214$1.35$1.35$269.70 million$267.56 millionViewListenView Earnings Details
4/23/2014Q114$1.45$1.45$283.02 million$262.90 millionViewListenView Earnings Details
1/30/2014Q413$1.40$1.43$278.55 million$276.30 millionViewListenView Earnings Details
10/17/2013Q313$1.34$1.36$267.21 million$273.16 millionViewN/AView Earnings Details
7/17/2013Q2 2013$1.31$1.32$267.24 million$263.14 millionViewListenView Earnings Details
4/17/2013Q1 2013$1.15$1.22$260.90 million$260.90 millionViewListenView Earnings Details
1/30/2013Q4 2012$1.13$1.17$246.49 million$254.46 millionViewListenView Earnings Details
10/17/2012$1.10$1.13ViewN/AView Earnings Details
7/18/2012$1.16$1.16ViewN/AView Earnings Details
4/18/2012$1.07$1.06ViewN/AView Earnings Details
2/1/2012$1.08$1.09ViewN/AView Earnings Details
10/19/2011$0.99$0.93ViewN/AView Earnings Details
4/19/2011$0.75$0.77ViewN/AView Earnings Details
2/9/2011$0.81$0.84ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Core Laboratories N.V. (NYSE:CLB)
2017 EPS Consensus Estimate: $2.62
2018 EPS Consensus Estimate: $3.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20173$0.39$0.81$0.53
Q2 20173$0.47$0.88$0.61
Q3 20173$0.55$0.97$0.72
Q4 20173$0.54$1.03$0.76
Q1 20181$0.73$0.73$0.73
Q2 20181$0.84$0.84$0.84
Q3 20181$1.00$1.00$1.00
Q4 20182$0.65$1.08$0.87
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Core Laboratories N.V. (NYSE:CLB)
Most Recent Dividend:8/14/2017
Annual Dividend:$2.20
Dividend Yield:2.26%
Dividend Growth:19.80% (3 Year Average)
Payout Ratio:134.15% (Trailing 12 Months of Earnings)
110.55% (Based on This Year's Estimates)
80.59% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Core Laboratories N.V. (NYSE:CLB)

Dividend History by Quarter for Core Laboratories N.V. (NYSE CLB)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/6/2017Quarterly$0.552.11%7/13/20177/17/20178/14/2017
4/19/2017quarterly$0.551.98%4/27/20174/28/20175/23/2017
1/10/2017Quarterly$0.551.8%1/18/20171/20/20172/17/2017
10/11/2016Quarterly$0.551.95%10/19/201610/21/201611/22/2016
7/7/2016Quarterly$0.557/14/20167/18/20168/15/2016
4/15/2016Quarterly$0.555/2/20165/4/20165/24/2016
1/11/2016Quarterly$0.552.28%1/20/20161/22/20162/19/2016
10/13/2015Quarterly$0.5510/21/201510/23/201511/24/2015
7/7/2015quarterly$0.552.02%7/15/20157/17/20158/17/2015
1/12/2015$0.551/21/20151/23/20152/20/2015
10/6/2014quarterly$0.501.39%10/16/201410/17/201411/25/2014
7/8/2014quarterly$0.507/16/20147/18/20148/18/2014
4/14/2014quarterly$0.501.33%4/23/20144/25/20145/23/2014
1/13/2014quarterly$0.501.05%1/22/20141/24/20142/21/2014
10/8/2013quarterly$0.320.73%10/16/201310/18/201311/20/2013
7/9/2013quarterly$0.320.82%7/17/20137/19/20138/19/2013
4/15/2013quarterly$0.321.01%4/24/20134/26/20135/24/2013
1/11/2013quarterly$0.321/22/20132/22/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Core Laboratories N.V. (NYSE:CLB)
Insider Ownership Percentage: 1.00%
Insider Trades by Quarter for Core Laboratories N.V. (NYSE:CLB)
Institutional Ownership by Quarter for Core Laboratories N.V. (NYSE:CLB)
Insider Trades by Quarter for Core Laboratories N.V. (NYSE:CLB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2017Michael StraughenDirectorBuy106$118.65$12,576.90View SEC Filing  
1/30/2017Martha Z CarnesDirectorBuy200$115.20$23,040.00View SEC Filing  
2/2/2016Jan Willem SodderlandDirectorBuy300$93.90$28,170.00View SEC Filing  
5/12/2015Michael C KearneyDirectorSell1,000$128.52$128,520.00View SEC Filing  
11/17/2014Mark F ElvigVPSell1,000$138.03$138,030.00View SEC Filing  
7/28/2014Richard L BergmarkCFOBuy7,000$147.31$1,031,170.00View SEC Filing  
3/7/2014Michael KearneyDirectorSell2,000$193.00$386,000.00View SEC Filing  
2/14/2014Mark ElvigVPSell1,500$186.64$279,960.00View SEC Filing  
10/21/2013Monty L DavisCOOSell5,704$197.33$1,125,570.32View SEC Filing  
8/7/2013Richard BergmarkCFOSell20,000$149.58$2,991,600.00View SEC Filing  
7/25/2013Charles Brigham MillerCAOSell11,648$147.81$1,721,690.88View SEC Filing  
7/25/2013Monty L DavisCOOSell5,948$149.12$886,965.76View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Core Laboratories N.V. (NYSE:CLB)
Latest Headlines for Core Laboratories N.V. (NYSE:CLB)
Source:
DateHeadline
finance.yahoo.com logoCore Laboratories NV – Value Analysis (NYSE:CLB) : September 19, 2017
finance.yahoo.com - September 19 at 10:18 PM
finance.yahoo.com logoCore Laboratories NV breached its 50 day moving average in a Bullish Manner : CLB-US : September 18, 2017
finance.yahoo.com - September 18 at 3:27 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - September 18 at 12:16 AM
247wallst.com logoJPMorgan Has 5 Top Pick Oil Service Stocks for the Rest of 2017
247wallst.com - September 13 at 6:29 PM
finance.yahoo.com logoOil Companies on Slippery Ground as Harvey Hampers Production
finance.yahoo.com - September 12 at 5:53 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - September 9 at 8:38 PM
finance.yahoo.com logoCorrelation between Crude Oil and Halliburton on September 5
finance.yahoo.com - September 8 at 5:35 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) PT Lowered to $112.00 at Royal Bank Of Canada
www.americanbankingnews.com - September 7 at 1:00 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) Updates Q3 Earnings Guidance
www.americanbankingnews.com - September 5 at 9:10 PM
finance.yahoo.com logoCore Lab Reports On Impact Of Hurricane Harvey, Updates Third Quarter 2017 Guidance
finance.yahoo.com - September 5 at 6:47 PM
americanbankingnews.com logoCowen and Company Reaffirms Hold Rating for Core Laboratories N.V. (CLB)
www.americanbankingnews.com - September 4 at 9:26 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) Lowered to Sell at ValuEngine
www.americanbankingnews.com - September 3 at 6:32 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) Receives "Buy" Rating from Royal Bank Of Canada
www.americanbankingnews.com - September 2 at 6:20 AM
nasdaq.com logoFirst Week of October 20th Options Trading For Core Laboratories (CLB)
www.nasdaq.com - August 30 at 4:18 PM
finance.yahoo.com logoETFs with exposure to Core Laboratories NV : August 25, 2017
finance.yahoo.com - August 25 at 6:59 PM
nasdaq.com logoCore Laboratories (CLB) Down 17.7% Since Earnings Report: Can It Rebound? - Nasdaq
www.nasdaq.com - August 25 at 3:24 AM
nasdaq.com logoCore Laboratories Stock Getting Very Oversold
www.nasdaq.com - August 24 at 5:21 PM
finance.yahoo.com logoCore Laboratories (CLB) Down 17.7% Since Earnings Report: Can It Rebound?
finance.yahoo.com - August 24 at 5:21 PM
finance.yahoo.com logoCore Laboratories NV : CLB-US: Dividend Analysis : July 17th, 2017 (record date) : By the numbers : August 24, 2017
finance.yahoo.com - August 24 at 5:21 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) Upgraded to "Outperform" by Credit Suisse Group
www.americanbankingnews.com - August 24 at 3:56 PM
fool.com logoCore Laboratories Stock Upgraded: What You Need to Know
www.fool.com - August 24 at 2:47 PM
finance.yahoo.com logoBehind Baker Hughes’s Correlation with Crude in Mid-August
finance.yahoo.com - August 22 at 5:49 PM
finance.yahoo.com logoCorrelation between Weatherford and Crude Oil on August 18
finance.yahoo.com - August 21 at 5:03 PM
fool.com logoHow Core Laboratories N.V. Makes Most of Its Money
www.fool.com - August 21 at 11:23 AM
finance.yahoo.com logoFlotek Industries’ Current Valuation versus Its Peers
finance.yahoo.com - August 18 at 5:18 PM
nasdaq.com logoNovember 17th Options Now Available For Core Laboratories (CLB) - Nasdaq
www.nasdaq.com - August 17 at 11:37 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - August 16 at 12:42 AM
finance.yahoo.com logoETFs with exposure to Core Laboratories NV : August 14, 2017
finance.yahoo.com - August 14 at 5:37 PM
finance.yahoo.com logoOilfield Tech & Innovation Day: Heavy Hitters, Cutting Edge Technologies coming to EnerCom Denver
finance.yahoo.com - August 9 at 5:27 PM
americanbankingnews.com logoHead-To-Head Survey: Core Laboratories N.V. (NYSE:CLB) and Carbo Ceramics (CRR)
www.americanbankingnews.com - August 9 at 8:40 AM
finance.yahoo.com logoCorrelation between Weatherford and Crude Oil on August 4
finance.yahoo.com - August 8 at 4:57 PM
americanbankingnews.com logoMorgan Stanley Lowers Core Laboratories N.V. (CLB) Price Target to $125.00
www.americanbankingnews.com - August 7 at 10:58 AM
americanbankingnews.com logoCore Laboratories N.V. (NYSE:CLB) Upgraded by ValuEngine to "Hold"
www.americanbankingnews.com - August 6 at 11:20 AM
finance.yahoo.com logoNOW Inc's Results Continue Heading in the Right Direction
finance.yahoo.com - August 2 at 6:01 PM
finance.yahoo.com logoWhere the World Gets Its Power
finance.yahoo.com - July 31 at 5:11 PM
finance.yahoo.com logoCore Laboratories NV :CLB-US: Earnings Analysis: Q2, 2017 By the Numbers : July 31, 2017
finance.yahoo.com - July 31 at 5:11 PM
americanbankingnews.com logoCore Laboratories N.V. (NYSE:CLB) Short Interest Update
www.americanbankingnews.com - July 31 at 7:04 AM
finance.yahoo.com logoWall Street’s Forecasts for TechnipFMC after Its 2Q17 Earnings
finance.yahoo.com - July 28 at 6:58 PM
americanbankingnews.com logoCore Laboratories N.V. (CLB) PT Lowered to $100.00
www.americanbankingnews.com - July 26 at 6:51 PM
finance.yahoo.com logoCore Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : July 26, 2017
finance.yahoo.com - July 26 at 5:50 PM
finance.yahoo.com logoCore Laboratories NV breached its 50 day moving average in a Bearish Manner : CLB-US : July 26, 2017
finance.yahoo.com - July 26 at 5:50 PM
americanbankingnews.com logoCore Laboratories N.V.'s (CLB) "Neutral" Rating Reaffirmed at UBS AG
www.americanbankingnews.com - July 26 at 2:41 PM
finance.yahoo.com logoWhat’s Schlumberger’s Correlation with Crude Oil after 2Q17?
finance.yahoo.com - July 26 at 3:16 AM
seekingalpha.com logoCore Laboratories' (CLB) CEO David Demshur on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - July 25 at 10:14 PM
finance.yahoo.com logoEdited Transcript of CLB earnings conference call or presentation 25-Jul-17 12:30pm GMT
finance.yahoo.com - July 25 at 10:14 PM
nasdaq.com logoCore Laboratories (CLB) Q2 Earnings Top Estimates, Sales Lag - Nasdaq
www.nasdaq.com - July 25 at 5:14 PM
americanbankingnews.com logoCore Laboratories N.V. (NYSE:CLB) Issues Earnings Results
www.americanbankingnews.com - July 25 at 9:08 AM
fool.com logoThe Recovery in Core Laboratories N.V.'s Results Accelerated in the Second Quarter
www.fool.com - July 25 at 9:00 AM
prnewswire.com logoCore Lab Reports Second Quarter 2017 Results: - PR Newswire (press release)
www.prnewswire.com - July 24 at 9:56 PM
finance.yahoo.com logoCore Laboratories beats 2Q profit forecasts
finance.yahoo.com - July 24 at 9:56 PM

Social

Chart

Core Laboratories N.V. (CLB) Chart for Friday, September, 22, 2017

This page was last updated on 9/22/2017 by MarketBeat.com Staff